NCT04337580 2026-04-13
FASN
Wake Forest University Health Sciences
Phase 2 Recruiting
Clinical Trials
28 trialsNCT03016741 2026-02-24
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
Northwestern University
Phase 4 Active not recruiting
NCT07376057 2026-01-29
Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not yet recruiting
NCT04717154 2026-01-06
INSPIRE
Radboud University Medical Center
Phase 2 Completed
NCT05743621 2025-11-21
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer
Weill Medical College of Cornell University
Phase 1 Recruiting
NCT05057013 2025-08-11
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
Cancer Research UK
Phase 1/2 Active not recruiting
NCT05944237 2025-06-08
HTL0039732 in Participants With Advanced Solid Tumours
Cancer Research UK
Phase 1/2 Recruiting
NCT03822845 2025-04-17
Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer
University of Iowa
Phase 2/3 Completed
NCT04962919 2025-02-11
LACOG 1818
Latin American Cooperative Oncology Group
Active not recruiting
NCT06276465 2024-12-20
PEACE8
UNICANCER
Phase 3 Recruiting
NCT04104607 2024-12-09
PSMAxCD3
University Hospital Tuebingen
Phase 1 Recruiting
NCT05393791 2024-11-26
ANZadapt
Leiden University Medical Center
Phase 2 Recruiting
NCT04918810 2024-11-22
GUIDE
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2 Terminated
NCT03248570 2024-11-20
Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects
University of California, San Francisco
Phase 2 Completed
NCT03017417 2024-07-18
COMRADE
Sheffield Teaching Hospitals NHS Foundation Trust
Phase NA Completed
NCT03389451 2024-07-12
68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer
University of Iowa
Phase 2/3 Completed
NCT03927391 2024-06-12
REDOSE
Radboud University Medical Center
Phase 4 Completed
NCT03388346 2024-02-15
68Ga PSMA in Preprostatectomy Patients
University of Iowa
Phase 2/3 Completed
NCT05902247 2023-06-13
225AcPSMAI&T
Erasmus Medical Center
Phase 1 Unknown
NCT04854369 2023-04-11
Firefly
Tulane University
No longer available
NCT04141709 2023-02-08
OLI-CR-P
Technische Universität Dresden
Phase NA Unknown
NCT04833517 2022-12-08
Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)
Universität des Saarlandes
Unknown
NCT05156450 2021-12-14
TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
West China Hospital
Phase 2 Unknown
NCT02866916 2021-01-20
PROSTIRNA
Institut Claudius Regaud
Phase 1 Withdrawn
NCT03173859 2020-11-18
AERA
University of Athens
Phase 2 Withdrawn
NCT04126915 2019-11-05
PTtWES
Changhai Hospital
Unknown
NCT02254785 2017-12-06
Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer
British Columbia Cancer Agency
Phase 2 Unknown
NCT01171729 2010-08-11
Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer
Samsung Medical Center
Phase 1/2 Completed